Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Therefore, this meta-analysis demonstrated that 8q24 polymorphisms (rs6983267 T>G, rs1447295 C>A, rs16901979 C>A, rs6983561 A>C and rs10090154 C>T) were associated with the susceptibility to PCa, which held the potential biomarkers for PCa risk. 29158792

2017

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Overall, though no association was observed between the rs</span>6983267 polymorphism and risk of prostate cancer, subgroup analysis according to ethnicity showed a significant association between the rs6983267 polymorphism and risk of prostate cancer among white European men [recessive model: GG vs TG + TT, OR=1.21, (95% CI: 1.03, 1.42), P=0.02]. 27009866

2016

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Similarly, in a subgroup analysis of European and Asian descent, our results revealed that there are associations between rs6983267 T/G polymorphism and PCa susceptibility with the dominant model (GG vs GT+TT), recessive model (GG+GT vs TT), and homozygote comparison (GG vs TT). 26782586

2015

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Three 8q24 polymorphisms (rs1447295 C>A, rs16901979 C>A, and rs6983267 T>G) have been extensively investigated for their association with prostate cancer (PCa) susceptibility, yet conclusions are contradictory. 26159557

2015

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01). 25315430

2014

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The polymorphism rs6983267 from region 3 of the chromosome 8q24 appears to be a prominent risk factor for PCa and a biomarker for cancer aggressiveness in the group of patients who presented higher levels of PSA at the time of diagnosis. 24224612

2014

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Significant associations were observed for rs4430796 TT with Gleason scores of ≥ 7 (OR = 1.76, 95% CI = 1.14-2.73) and prostate-specific antigen (PSA) levels of ≥ 10 ng/ml at diagnosis (OR = 1.63, 95% CI = 1.01-2.63), as well as for rs6983267 GG with stage 3-4 CaPs (OR = 1.91, 95% CI = 1.01-3.61). 22561070

2013

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The results of the meta-analyses indicate that rs6983267, rs1447295, rs6983561, rs7837688, rs16901979, and DG8S737 are significantly associated with a higher risk for PCa for at least one race, whereas the variants rs13254738 and rs7000448 are not. 22382457

2012

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE We demonstrate that trans-acting RNA molecules facilitating resistance to androgen depletion (RAD) in vitro and castration-resistant phenotype (CRP) in vivo of PC contain intergenic 8q24-locus SNP variants (rs1447295; rs16901979; rs6983267) that were recently linked with increased risk of PC. 22067658

2011

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE There was a tendency towards significantly increased risk for SNPs rs1447295 and rs6983267 in men with early-onset prostate cancer. 21557270

2011

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Correlation between genotypes and biopsy outcome (positive or negative) and Gleason score (≤6 or >6) were studied by univariate and multivariable analysis. rs1447295 and rs6983267 risk variants were found to be associated with the presence of PCa in univariate analysis. rs6983267 genotype remained significantly linked to a positive biopsy (odds ratio [OR] = 1.66, 95% confidence interval [CI]: 1.06-2.59, P = 0.026) in multivariable analysis, but rs1447295 genotype did not (OR = 1.47, 95% CI: 0.89-2.43, P = 0.13).When biopsy outcome was stratified according to Gleason score, risk variants of rs1447295 were associated with aggressive disease (Gleason score ≥7) in univariate and multivariable analysis (OR = 2.05 95% CI: 1.10-3.79, P = 0.023). rs6983267 GG genotype was not related to aggressiveness. 21308149

2011

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE A highly significant association (odds ratio=2.84 and p-value=0.002) was found between rs6983267 and prostate cancer in the Greek population. 22070222

2011

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Forty-nine tagging SNPs including three previously reported significant variants (rs1447295, rs6983267, rs16901979) and seven variants in the 5' upstream region of the MYC proto-oncogene were tested for association with susceptibility to PC and tumor aggressiveness in 596 histologically verified PC cases and 567 ethnically matched controls. 19562729

2009

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The A allele of rs1447295 was significantly associated with the risk of sporadic prostate cancer (p = 0.04; age-adjusted OR, 1.34), while the G allele of rs6983267 showed a trend towards being a high-risk allele (p = 0.06; age-adjusted OR, 1.27). 19602258

2009

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The highest significance in Caucasian men was found for rs6983267; the AA genotype reduced the risk for PCa [odds ratio (OR) = 0.48, 95% confidence interval (CI) = 0.35-0.65, P = 2.74 x 10(-6)]. 19528667

2009

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE A single nucleotide polymorphism (SNP) rs6983267, located within the 8q24 region, is strongly associated with risk of colorectal and prostate cancer. 19895682

2009

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE The rs6983267 G allele did not show significant association with susceptibility to PC (PC vs. non-PC: P = 0.967; OR, 1.00; 95%CI = 0.83-1.21). 18726982

2008

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE There was no joint effect between SNPs rs16901979 A and rs6983267 G. These results confirm the significance of these SNPs in prostate cancer etiology in a previously unstudied population who do not undergo prostate cancer screening and are diagnosed with severe disease. 18768513

2008

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE One marker, rs6983267 on chromosome 8q24, has been linked to both colon and prostate cancer, and is therefore a good candidate for a multicancer susceptibility marker. 19047180

2008

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Single nucleotide polymorphisms (SNPs) rs6983561 and rs6983267 showed the strongest evidence of prostate cancer association. 18360876

2008

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE A meta-analysis across 10 studies including our results of four 8q24 variants (rs1442295 and DG8S737-region 1, rs16901979-region 2, and rs6983267-region 3) and prostate cancer risk demonstrated strong associations across a wide array of study designs and populations. 18231127

2008

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE We genotyped three variants associated with prostate cancer (rs10090154, rs13254738, and rs7000448), one associated with both prostate and colorectal cancer (rs6983267), and one associated with breast cancer (rs13281615) in a series of 1,499 breast cancer cases and 1,390 controls. 18349290

2008

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE A combined analysis with four additional studies (total: 4,296 cases and 4,299 controls) confirms association with prostate cancer for rs6983267 in the centromeric locus (P = 9.42 x 10(-13); heterozygote odds ratio (OR): 1.26, 95% confidence interval (c.i.): 1.13-1.41; homozygote OR: 1.58, 95% c.i.: 1.40-1.78). 17401363

2007

dbSNP: rs6983267
rs6983267
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.800 GeneticVariation BEFREE Analysis of the National Cancer Institute's Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer association study database alone and in combination with our data provided further evidence for this second prostate cancer risk locus; in the combined analysis, the allele frequencies for rs6983267 differed statistically significantly between case patients and control subjects (P = 1.61 x 10(-9)). 17925536

2007